New hope for advanced cancer? early trial of FS-8002 begins
NCT ID NCT06832982
First seen Jan 11, 2026 · Last updated Jun 18, 2026 · Updated 27 times
Summary
This early-phase study tests a new drug called FS-8002 in 66 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it helps control the cancer. Participants will receive FS-8002 alone or in combination, and researchers will monitor side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
Contact
Contact
-
Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute,Shandong Cancer Hospital)
RECRUITINGShandong, Jinan, 250117, China
Contact
Contact
-
Fujian Cancer hospital
RECRUITINGFujian, Fuzhou, 350013, China
Contact
Contact
-
Harbin Medical University Cancer Hospital
RECRUITINGHeilongjiang, Harbin, 150081, China
Contact
Contact
-
Hebei General Hospital
RECRUITINGHebei, Shijiazhuang, 050010, China
Contact
Contact
Contact
-
Hubei Cancer Hospital
RECRUITINGHubei, Wuhan, 430079, China
Contact
Contact
-
Meizhou People's Hospital
RECRUITINGGuangdong, Meizhou, 514031, China
Contact
Contact
-
The First Affiliated Hospital of China Medical University
RECRUITINGShenyang, Shenyang, 110001, China
Contact
Contact
-
The First Affiliated Hospital of Zhejiang Medical University
RECRUITINGZhejiang, Hangzhou, 310003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Union Hospital, Tongji Medical College
RECRUITINGHubei, Wuhan, 430022, China
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.